Advances in Nanoparticle-Based Drug Delivery Systems for Improved Cancer Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 309
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanotechnology can benefit biomedicines. In particular, the development of nanoparticle-based drug delivery systems has drawn attention as one of the most potential ways to fight cancer. Many materials have been used to construct different types of nanoparticle-based drug delivery systems, which have shown success to some extent in overcoming the drawbacks related to conventional drugs; however, the use of nanoparticle-based drug delivery systems in cancer therapy requires further research to increase the viability as translatable nanomedicine.
Therefore, the multi-disciplinary topics of interest for this Special Issue include but are not limited to the development of different drug delivery systems, advances of nanoparticles/nanotechnology in drug delivery, and the translational feasibilities of nano-based drug delivery systems for improved cancer therapy. We welcome both research and review articles.
Dr. Dong-Ming Huang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- nanostructured materials
- drug delivery
- cancer therapy
- biomaterials
- anticancer drugs
- nanomedicine
- biocompatibility
- theranostics
- molecular mechanism
